Nanoparticle conjugated synthetic opioid prodrugs and methods of their uses
AssigneeVirginia Commonwealth University
InventorsYan Zhang, Hu Yang, Dana Selley, William Dewey, Hamid Akbarali
Life of this patent
Estimating the term…
Abstract
Provided herein are nanoparticle conjugated synthetic opioid prodrugs that target the peripheral mu opioid receptor (MOR). The prodrugs exhibit long-lived bioavailability, do not compromise the analgesic effects of opioids administered for pain relief (and in some cases can be used for pain relief), and do not induce opioid withdrawal symptoms, when their use is discontinued. Certain of the prodrugs are especially useful for the prevention and/or treatment of unwanted opioid-induced side effects such as opioid-induced constipation (OIC).
Claims4
A compound having the general formula:
- where
- m=0-16;
- y=5-20;
- z=10-30;
- and
- R′ and R″ are independently hydrogen or a substituted or unsubstituted aromatic or aliphatic moiety.
A method of preventing or treating opioid induced constipation (OIC) in a subject in need thereof, comprising
- administering to the subject a therapeutically effective amount of a compound having the general formula
- where
- m=0-16;
- y=5-20;
- z=10-30;
- and
- R′ and R″ are independently hydrogen or a substituted or unsubstituted aromatic or aliphatic moiety.
Dependencies are inferred from the claim text.